Scarica l'app Stockscreener
1.35
2.17%
-0.03
Dopo l'orario di chiusura:
1.41
0.06
+4.44%
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Layoff Tracker: Gilead Sciences Will Lay Off 104 Employees at California HQ - BioSpace
FY2024 EPS Estimates for BCAX Cut by Cantor Fitzgerald - Defense World
Compass Therapeutics (NASDAQ:CMPX) Cut to Market Perform at Leerink Partners - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat
What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock - MSN
2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious - MSN
Leerink Partnrs Downgrades Compass Therapeutics (NASDAQ:CMPX) to Hold - MarketBeat
DelphX announces non-brokered unit private placement - MSN
U.S. STOCKS FuelCell Energy, consumer goods stocks, Rocket Companies - XM
Compass Therapeutics (NASDAQ:CMPX) Lowered to Market Perform Rating by Leerink Partners - MarketBeat
Wedbush Predicts Higher Earnings for Compass Therapeutics - MarketBeat
Research Analysts Issue Forecasts for CMPX FY2024 Earnings - MarketBeat
Janus Henderson Group PLC's Strategic Reduction in Compass Thera - GuruFocus.com
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment - Benzinga
Research Analysts Offer Predictions for CMPX FY2028 Earnings - MarketBeat
Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress - TipRanks
Compass Therapeutics to Participate in Upcoming Investor Events - The Manila Times
Compass Therapeutics (CMPX) to Present at Stifel and Jefferies Healthcare Conferences | CMPX Stock News - StockTitan
PD-1 and PD-L1 Inhibitors Market Projected to Surge, Reaching USD XX Billion by 2031 As Revealed In New Report - WhaTech
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewswire
Compass Therapeutics Reports Key Trial Progress, $135M Cash Runway Through 2027 | CMPX Stock News - StockTitan
Compass Therapeutics Inc (CMPX) Quarterly 10-Q Report - Quartzy
Compass Therapeutics' (CMPX) Buy Rating Reiterated at HC Wainwright - MarketBeat
Compass Therapeutics Presents Novel Biomarker Data Related - GlobeNewswire
US Penny Stocks To Watch: 3 Picks With Market Caps Over $40M - Simply Wall St
Treatment Resistant Depression Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart
Treatment Resistant Depression Pipeline Therapeutics, - openPR
Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance
Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine
Treatment Resistant Depression Clinical Trials 2024: FDA - openPR
Biotech stock tumbles after unexplained 1,446% gain - MSN
Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News
Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - Investing News Network
CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle
Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World
JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR
Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com
Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire
Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News
American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat
Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World
Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World
Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World
NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World
PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World
Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World
Gencor Industries, Inc. (NASDAQ:GENC) Shares Acquired by Renaissance Technologies LLC - Defense World
First Trust Cloud Computing ETF (NASDAQ:SKYY) Sets New 52-Week High at $103.17 - Defense World
Amgen’s stock falls 4% as analysts say drug updates lag competitors - MSN
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News
Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):